These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 27239874

  • 1. Considering the Future of Pharmaceutical Promotions in Social Media Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Carpentier FR.
    Int J Health Policy Manag; 2016 Feb 09; 5(4):283-5. PubMed ID: 27239874
    [Abstract] [Full Text] [Related]

  • 2. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H.
    Int J Health Policy Manag; 2015 Aug 25; 4(12):813-21. PubMed ID: 26673465
    [Abstract] [Full Text] [Related]

  • 3. The Conundrum of Online Prescription Drug Promotion Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Wanasika I.
    Int J Health Policy Manag; 2016 Mar 26; 5(6):391-2. PubMed ID: 27285519
    [Abstract] [Full Text] [Related]

  • 4. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Doran E.
    Int J Health Policy Manag; 2016 Feb 21; 5(5):333-5. PubMed ID: 27239884
    [Abstract] [Full Text] [Related]

  • 5. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mackey TK.
    Int J Health Policy Manag; 2016 Feb 03; 5(4):271-4. PubMed ID: 27239871
    [Abstract] [Full Text] [Related]

  • 6. Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Rollins BL.
    Int J Health Policy Manag; 2016 Feb 10; 5(4):287-8. PubMed ID: 27239875
    [Abstract] [Full Text] [Related]

  • 7. Future Challenges and Opportunities in Online Prescription Drug Promotion Research Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Southwell BG, Rupert DJ.
    Int J Health Policy Manag; 2016 Jan 16; 5(3):211-3. PubMed ID: 26927597
    [Abstract] [Full Text] [Related]

  • 8. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mintzes B.
    Int J Health Policy Manag; 2016 Feb 18; 5(5):329-31. PubMed ID: 27239883
    [Abstract] [Full Text] [Related]

  • 9. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
    Tyrawski J, DeAndrea DC.
    J Med Internet Res; 2015 Jun 01; 17(6):e130. PubMed ID: 26032738
    [Abstract] [Full Text] [Related]

  • 10. Medical Marketing in the United States, 1997-2016.
    Schwartz LM, Woloshin S.
    JAMA; 2019 Jan 01; 321(1):80-96. PubMed ID: 30620375
    [Abstract] [Full Text] [Related]

  • 11. FDA actions against health economic promotions, 2002-2011.
    Neumann PJ, Bliss SK.
    Value Health; 2012 Jan 01; 15(6):948-53. PubMed ID: 22999146
    [Abstract] [Full Text] [Related]

  • 12. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C.
    J Med Internet Res; 2016 Feb 18; 18(2):e33. PubMed ID: 26892749
    [Abstract] [Full Text] [Related]

  • 13. Legal considerations for social media marketing by pharmaceutical industry.
    Yang YT, Chen B.
    Food Drug Law J; 2014 Feb 18; 69(1):39-51, ii. PubMed ID: 24772685
    [Abstract] [Full Text] [Related]

  • 14. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL, Katz KA.
    Br J Dermatol; 2006 May 18; 154(5):950-8. PubMed ID: 16634900
    [Abstract] [Full Text] [Related]

  • 15. Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies.
    Nguyen D, Seoane-Vazquez E, Rodriguez-Monguio R, Montagne M.
    BMC Health Serv Res; 2013 Jan 22; 13():27. PubMed ID: 23339419
    [Abstract] [Full Text] [Related]

  • 16. Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019.
    Wagoner KG, Lazard AJ, Romero-Sandoval EA, Reboussin BA.
    Cannabis Cannabinoid Res; 2021 Dec 22; 6(6):559-563. PubMed ID: 34142863
    [Abstract] [Full Text] [Related]

  • 17. Drug Advertising Violations: A Longitudinal Trend Analysis of FDA Enforcement Letters from 2005 to 2019.
    Zagrodney KAP, Sheikhan NY, Pinto A, Sheikhan T, Witek TJ.
    Pharmaceut Med; 2021 Jan 22; 35(1):31-38. PubMed ID: 33453042
    [Abstract] [Full Text] [Related]

  • 18. A review of FDA warning letters and notices of violation issued for patient-reported outcomes promotional claims between 2006 and 2012.
    Symonds T, Hackford C, Abraham L.
    Value Health; 2014 Jun 22; 17(4):433-7. PubMed ID: 24969004
    [Abstract] [Full Text] [Related]

  • 19. FDA actions against misleading or unsubstantiated economic and quality-of-life promotional claims: an analysis of warning letters and notices of violation.
    Stewart KA, Neumann PJ.
    Value Health; 2002 Jun 22; 5(5):390-7. PubMed ID: 12201856
    [Abstract] [Full Text] [Related]

  • 20. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.
    Klara K, Kim J, Ross JS.
    J Gen Intern Med; 2018 May 22; 33(5):651-658. PubMed ID: 29484575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.